MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 146 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,084 | +12.3% | 206 | +77.6% | 0.00% | – |
| Q2 2023 | $26,796 | +46910.5% | 116 | -50.8% | 0.00% | – |
| Q1 2023 | $57 | +103.6% | 236 | +145.8% | 0.00% | – |
| Q4 2022 | $28 | -99.6% | 96 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | -53.3% | 96 | -54.9% | 0.00% | – |
| Q2 2022 | $15,000 | -53.1% | 213 | -35.1% | 0.00% | – |
| Q1 2022 | $32,000 | -68.6% | 328 | -81.5% | 0.00% | -100.0% |
| Q4 2021 | $102,000 | -55.1% | 1,775 | -37.5% | 0.00% | 0.0% |
| Q3 2021 | $227,000 | -18.1% | 2,842 | -0.1% | 0.00% | -50.0% |
| Q2 2021 | $277,000 | -24.7% | 2,845 | -9.5% | 0.00% | 0.0% |
| Q1 2021 | $368,000 | +5.1% | 3,145 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $350,000 | +22.0% | 3,145 | +30.1% | 0.00% | 0.0% |
| Q3 2020 | $287,000 | -40.8% | 2,417 | -43.5% | 0.00% | -50.0% |
| Q2 2020 | $485,000 | – | 4,281 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |